Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Oct. 31, 2020	Nov. 02, 2019	Nov. 03, 2018	[1]
Revenue
Revenue	$ 5,603,056	$ 5,991,065	$ 6,224,689
Costs and Expenses
Cost of sales	1,912,578	1,977,315	1,974,293
Gross margin	3,690,478	4,013,750	4,250,396
Operating expenses:
Research and development	1,050,519	1,130,348	1,165,047
Selling, marketing, general and administrative	659,923	648,094	695,540
Amortization of intangibles	429,455	429,041	428,902
Special charges	52,337	95,659	61,318
Total operating expenses	2,192,234	2,303,142	2,350,807
Operating income	1,498,244	1,710,608	1,899,589
Nonoperating expense (income):
Interest expense	193,305	229,075	253,589
Interest income	(4,305)	(10,229)	(9,383)
Other, net	(2,373)	6,034	69
Total nonoperating (income) expense	186,627	224,880	244,275
Earnings
Income before income taxes	1,311,617	1,485,728	1,655,314
Provision for income taxes	90,856	122,717	148,334
Net income	$ 1,220,761	$ 1,363,011	$ 1,506,980
Shares used to compute earnings per common share (in shares)
Shares used to compute earnings per share - Basic (in shares)	368,633	369,133	370,430
Shares used to compute earnings per share - Diluted (in shares)	371,973	372,871	374,938
Basic earnings per common share (in dollars per share)	$ 3.31	$ 3.68	$ 4.05
Diluted earnings per common share (in dollars per share)	$ 3.28	$ 3.65	$ 4.00

[1] Balances have been restated to reflect the adoption of Accounting Standards Update (ASU) 2014-09, Revenue from Contracts with Customers (ASU 2014-09). See Note 2a, Principles of Consolidation, of the Notes to Consolidated Financial Statements.